Patents by Inventor Hongtao Jin

Hongtao Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG INJURY, A PREPARATION METHOD THEREFOR AND A USE THEREOF
    Publication number: 20240000880
    Abstract: The disclosure relates to a pharmaceutical composition having the efficacy of preventing and treating lung injury, a preparation method therefor and a use thereof. The composition comprises a grape powder with a content of 1-25% (w/w), a grape seed extract with a content of 0.5-15% (w/w) and a pharmaceutically acceptable carrier. The composition of the disclosure has the efficacy of preventing and treating lung injury, oxidative injury, inhibiting pulmonary fibrosis, regulating lipid metabolism, and the like.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 4, 2024
    Inventors: Hongtao JIN, Peicheng ZHANG, Jinlan ZHANG, Jiandong JIANG, Ping ZHANG, Yangyang LI
  • Use of ?-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for treatment of psoriasis
    Patent number: 10058611
    Abstract: The present invention relates to a use of alpha-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis. The use is suitable for various type of psoriasis by utilizing photodynamic therapy. The photosensitizer is used to treat psoriasis by utilizing laser wave length of 670 nm, with high light sensitivity, fast photobleaching, short time needed in protection from light, and avoiding potential toxic and side-effect of photochemistry therapy by using ultraviolet irradiation. The preparation used in the use of ?-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis includes solution, cream, nanomicelle, microsphere etc, and mode of administration can be systemic or topical administration. The practicability of treating psoriasis by photodynamic therapy has been validated on cell and animal model. The use achieves perfect effect.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: August 28, 2018
    Assignee: BEIJING GUIQIANJIN MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Hanqing Liu, Aiping Wang, Jinfeng Wei, Hongtao Jin, Qianaian Zhang, Ni Lin, Zhihuan Jiang, Xiaodan Yan, Ye Li, Jingyi Feng, Yingming Wang
  • USE OF ALPHA-(8-QUINOLINYLOXY) MONO-SUBSTITUTED PHTHALOCYANINE ZINC FOR TREATMENT OF PSORIASIS
    Publication number: 20170296662
    Abstract: The present invention relates to a use of alpha-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis. The use is suitable for various type of psoriasis by utilizing photodynamic therapy. The photosensitizer is used to treat psoriasis by utilizing laser wave length of 670 nm, with high light sensitivity, fast photobleaching, short time needed in protection from light, and avoiding potential toxic and side-effect of photochemistry therapy by using ultraviolet irradiation. The preparation used in the use of ?-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis includes solution, cream, nanomicelle, microsphere etc, and mode of administration can be systemic or topical administration. The practicability of treating psoriasis by photodynamic therapy has been validated on cell and animal model. The use achieves perfect effect.
    Type: Application
    Filed: September 2, 2014
    Publication date: October 19, 2017
    Inventors: Hanqing Liu, Aiping Wang, Jinfeng Wei, Hongtao Jin, Qianaian Zhang, Ni Lin, Zhihuan Jiang, Xiaodan Yan, Ye Li, Jingyi Feng, Yingming Wang